As AI becomes more prevalent, organizations need to leverage the power of scope, scale, speed, and human-AI collaboration for ...

Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 11th Edition of their annual conference, "Merck Foundation Africa Asia Luminary", under the patronage of The President of ...

There is a tidal wave of inheritance coming from an ageing Boomer generation to Millennials and Gen-Z which should be welcome ...

The Dow has dropped 0.8% week to date, while the S&P 500 and Nasdaq are down around 1.8% and 2.3%, respectively. Thursday was also the final trading day of what has been a choppy month for the market ...

Merck (MRK) will be in focus as company beats revenue forecasts despite in line earnings amid strong Keytruda sales in Q3 ...

Investing.com -- Merck and Co. (NYSE:MRK) has posted better-than-anticipated third-quarter profit thanks to solid demand for its crucial cancer treatment Keytruda, although the drugmaker warned of ...

The Gardasil franchise is the company's second largest sales driver behind Keytruda, and Merck remains steadfast it can garner more than $11 billion from the key product in 2030. Fewer than 10% of ...

Merck and Co. (NYSE:MRK) has posted better-than-anticipated third-quarter profit thanks to solid demand for its crucial cancer treatment Keytruda, although the drugmaker warned of ongoing sluggishness ...

RAHWAY, N.J. (AP) — RAHWAY, N.J. (AP) — Merck & Co. (MRK) on Thursday reported third-quarter profit of $3.16 billion. On a per-share basis, the Rahway, New Jersey-based company said it had ...

Merck KGaA said its cell-tumor treatment Pimicotinib met its primary endpoint in a late-stage trial. The German pharma company said Tuesday that its experimental drug showed significant improvement in ...

Adjusted for one-time items that included a 79-cent-a-share charge related to the business development deals, EPS came to $1.57, ahead of the FactSet consensus of $1.48. Sales rose 4% to $16.657 ...